25 agosto 2020
Comments (0)
Rassegna Stampa
Like
[vc_row][vc_column][vc_column_text]In an 80,000 m2 site 20 miles from Rome, young researchers from around the world work day and night making history. They have played a key role in the development of the Covid-19 vaccine, after the Jenner Institute (expert in coronavirus) sent them the viral inoculum and asked them for help. IRBM in Pomezia (Rome) has in fact a great experience in adenovirus, the viral vector. «We are producing and shipping the doses: phase III is underway» say Piero Di Lorenzo, President of IRBM, «if everything goes as planned, and it’s a big if, the first doses could be available in Italy between November and December». For IRBM – 43 million turnover reflecting the activity of a centre of excellence – this is an epoch-making challenge.[/vc_column_text][/vc_column][/vc_row][vc_row][vc_column][vcex_button url=”https://www.irbm.com/wp-content/uploads/IL-MATTINO-web_20200723.pdf” download_attribute=”true” icon_right=”fa fa-download” icon_right_padding=”5″]Download the article [/vcex_button][/vc_column][/vc_row]
English
